Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease

Clinical trial NCT01539031 · COMPLETED

Trial details

NCT number: NCT01539031
Sponsor: Eisai Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Type Dementia

Start date: 2012-03-01
Primary completion: 2015-01-01
Enrollment: 351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.